The cDNA 385C to A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) is associated with overweight/obesity but not with binge eating disorder in overweight/obese women

Psychoneuroendocrinology

Volumn 33, Issue 4, 2008, Pages 546-550

  Monteleone, Palmiero ^a   Tortorella, Alfonso ^a   Martiadis, Vassilis ^a   Di Filippo, Carmela ^a   Canestrelli, Benedetta ^a   Maj, Mario ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Binge eating disorder; Endocannabinoids; FAAH gene; Obesity; Polymorphisms

Indexed keywords

FATTY ACID AMIDASE;

ADULT; ARTICLE; BINGE EATING DISORDER; BODY WEIGHT; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MUTATIONAL ANALYSIS; OBESITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AMIDOHYDROLASES; ANALYSIS OF VARIANCE; BODY WEIGHT; BULIMIA NERVOSA; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ENDOCANNABINOIDS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINEAR MODELS; MIDDLE AGED; MUTATION, MISSENSE; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES;

EID: 41849145672     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2008.01.004     Document Type: Article

References (22)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. fourth ed (1994), American Psychiatric Press, Washington, DC
2. Chiang K., Gerber A.L., Sipe J.C., and Cravatt B.F. Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. Hum. Mol. Genet. 13 (2004) 1-7
3. Cote M., Matias I., Lemieux I., Petrosino S., Almeras N., Despres J.P., and Di Marzo V. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. Int. J. Obes. 31 (2007) 692-699
4. Després J.P., Golay A., and Sjöström L. Rimonabant in obesity-lipids study group. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N. Engl. J. Med. 353 (2005) 2121-2134
5. Di Marzo V., Goparaju S.K., Wang L., Liu J., Batkai S., Jarai Z., Fezza F., Miura G.I., Palmiter R.D., Sugiura T., and Kunos G. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410 (2001) 822-825
6. Dinh T.P., Carpenter D., Leslie F.M., Freund T.F., Katona I., Sensi S.L., Kathuria S., and Piomelli D. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. USA 99 (2002) 10819-10824
7. Engeli S., Bohnke J., Feldpausch M., Gorzelniak K., Janke J., Batkai S., Pacher P., Harvey-White J., Luft F.C., Sharma A.M., and Jordan J. Activation of the peripheral endocannabinoid system in human obesity. Diabetes 54 (2005) 2838-2843
8. First M.B., Spitzer R.L., Gibbon M., and Williams J.B. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Ed. (SCID-I/P, Version 2) (1995), New York State Psychiatric Institute, Biometrics Research Department, New York
9. First M.B., Gibbon M., Spitzer R.L., and Williams J.B.W. Structured Clinical Interview for Axis I DSM-IV Disorders-Non-Patient Ed-(SCID-I/NP, Version 2.0) (1996), New York State Psychiatric Institute, Biometrics Research Department, New York
10. Giang D.K., and Cravatt B.F. Molecular characterization of human and mouse fatty acid amide hydrolases. Proc. Natl. Acad. Sci. USA 94 (1997) 2238-2242
11. Harrold J.A., Elliott J.C., King P.J., Widdowson P.S., and Williams G. Downregulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food?. Brain Res. 952 (2002) 232-238
12. Jensen D.P., Andreasen C.H., Andersen M.K., Hansen L., Eiberg H., Borch-Johnsen K., Jorgensen T., Hansen T., and Pedersen O. The functional Pro129Thr variant of the FAAH gene is not associated with various fat accumulation phenotypes in a population-based cohort of 5801 whites. J. Mol. Med. 85 (2007) 445-449
13. Matias I., and Di Marzo V. Endocannabinoids and the control of energy balance. Trends Endocrinol. Metab. 18 (2007) 27-37
14. Matias I., Gonthier M.P., Orlando P., Martiadis V., De Petrocellis L., Cervino C., Petrosino S., Hoaureau L., Festy F., Pasquali R., Roche R., Maj M., Pagotto U., Monteleone P., and Di Marzo V. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J. Clin. Endocrinol. Metab. 91 (2006) 3171-3180
15. Monteleone P., Matias I., Martiadis V., De Petrocellis L., Maj M., and Di Marzo V. Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. Neuropsychopharmacology 30 (2005) 1216-1221
16. Ravinet T.C., Arnone M., Delgorge C., Gonalons N., Keane P., Maffrand J.P., and Soubrie P. Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am. J. Physiol. 284 (2003) R345-R353
17. Ravinet T.C., Delgorge C., Menet C., Arnone M., and Soubrie P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int. J. Obes. Relat. Metab. Disord. 28 (2004) 640-648
18. Sipe J.C., Chiang K., Gerber A.L., Beutler E., and Cravatt B.F. A missense mutation in human fatty acid amide hydrolase associated with problem drug use. Proc. Natl. Acad. Sci. USA 99 (2002) 8394-8399
19. Sipe J.C., Waalen J., Gerber A., and Beutler E. Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH). Int. J. Obesity 29 (2005) 755-759
20. Spitzer R.L., Yanovski S., Wadden T., Wing R., Marcus M.D., Stunkard A., Devlin M., Mitchell J., Hasin D., and Horne R.L. Binge eating disorder: its further validation in a multisite study. Int. J. Eat. Disord. 13 (1993) 137-153
21. Wittke-Thompson J.K., Pluzhnikov A., and Cox N.J. Rational inferences about departures from Hardy-Weinberg equilibrium. Am. Hum. Genet. 76 (2005) 967-986
22. World Health Organization. Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation on Obesity (WHO/NUT/NCD) (1998), WHO, Geneva